Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2013
11/05/2013US8575099 Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof
11/05/2013US8575098 Biopolymer, implant comprising it and uses thereof
11/05/2013US8575097 Exendin variant and conjugate thereof
11/05/2013US8575095 Active cores of peptide triazole HIV-1 entry inhibitors
11/05/2013US8575094 Use of type-B lantibiotic-based compounds having antimicrobial activity
11/05/2013US8575093 Composition and method for treating Streptococcus pneumoniae infection
11/05/2013US8575090 Amylin analogues and pharmaceutical compositions thereof
11/05/2013US8575089 Composition for preventing or treating inflammation
11/05/2013US8575088 Method of preventing acute or sub-acute hepatic failure by administering a long-acting recombinant human soluble tumor necrosis factor alpha receptor II fusion protein
11/05/2013US8575087 Treatment of cancers with A-8R peptide
11/05/2013US8574909 Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter gene
11/05/2013US8574863 Alkaline phosphatase for treating an inflammatory disease of the gastro-intestinal tract
11/05/2013US8574860 Biomarkers for the detection and screening of down syndrome
11/05/2013US8574857 Method and means for treatment of osteoarthritis
11/05/2013US8574851 Prediction and prevention of preeclampsia
11/05/2013US8574640 Combined effects of nutrients on proliferation of stem cells
11/05/2013US8574612 Medical devices having a coating of biologic macromolecules
11/05/2013US8574601 Sustained-release polymer micelle disruptable by HDL
11/05/2013US8574597 Immunogenic compositions for the prevention and treatment of meningococcal disease
11/05/2013US8574586 KDR peptides and vaccines comprising the same
11/05/2013US8574585 KDR peptides and vaccines comprising the same
11/05/2013US8574584 EphA2 T cell epitopes and uses therefor
11/05/2013US8574582 Methods for mediating fibrotic response
11/05/2013US8574577 VEGF antibodies comprising modular recognition domains
11/05/2013US8574570 Bi-stable quantum wire array of self-assembled nanomedicine and the preparation method therefor
11/05/2013US8574569 Stabilized protease composition
11/05/2013US8574563 Hepatitis C virus inhibitors
11/05/2013US8574548 Antagonists of ligands and uses thereof
11/05/2013US8574315 Electrospun structures and methods for forming and using same
11/05/2013CA2576049C Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning
11/05/2013CA2558050C Methods and compositions for the treatment of gastrointestinal disorders
11/05/2013CA2529103C Use of a recombinant vector encoding il-10 for treating neuropathic pain
11/05/2013CA2514485C Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
11/05/2013CA2512673C 2-o sulfatase compositions and related methods
11/05/2013CA2462512C Use of collagenase to facilitate guide wire crossing in total arterial occlusions
11/05/2013CA2461305C Methods of suppressing microglial activation and systemic inflammatory responses
11/05/2013CA2461176C Treatment of central nervous system disorders by use of pdgf or vegf
11/05/2013CA2398979C Novel bee venom polypeptides and methods of use thereof
11/05/2013CA2394015C Tweak receptor
11/05/2013CA2364417C Peroral gene therapy of diabetes and obesity
11/05/2013CA2341037C Bioactive peptides
10/2013
10/31/2013WO2013163606A1 Vascular endothelial growth factor antagonists and methods for their use
10/31/2013WO2013163423A1 Compositions and methods for wound healing and tissue repair
10/31/2013WO2013163422A1 Growth factors for the treatment of mycobacterial infection
10/31/2013WO2013163419A1 Broad spectrum erbb ligand binding molecules and methods for their use
10/31/2013WO2013163248A1 Par4 agonist peptides
10/31/2013WO2013163187A1 Systems and methods for targeted imaging and ablation of cardiac cells
10/31/2013WO2013163162A1 Site-specific enzymatic modification of exendins and analogs thereof
10/31/2013WO2013162828A1 Use of cpg oligonucleotides co-formulated with an antibiotic to accelarate wound healing
10/31/2013WO2013162760A1 Novel cyclotides with anticancer activity
10/31/2013WO2013162751A1 Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
10/31/2013WO2013162746A1 Staphylococcal coagulase antigens and methods of their use
10/31/2013WO2013162742A1 Methods and compositions for treatment of multidrug-resistant bacterial and fungal infections
10/31/2013WO2013162718A1 Insulin secretion stimulated by humanin and analogs thereof
10/31/2013WO2013162202A1 Anti-inflammatory composition comprising bean extract using flower wrap fermentation, and method for preparing same
10/31/2013WO2013162078A1 Therapeutic agent for injury in epithelium and endothelium
10/31/2013WO2013162050A1 Lactoferrin fusion protein and method for producing same
10/31/2013WO2013162021A1 Prophylactic or therapeutic agent for hepatic diseases
10/31/2013WO2013161896A1 Sustained release carrier for drugs
10/31/2013WO2013161895A1 Bone repair promoter
10/31/2013WO2013160895A1 Peptides and use thereof in the treatment of large cell lung cancer
10/31/2013WO2013160492A1 Combination therapy for the treatment of metabolic diseases
10/31/2013WO2013160005A1 Pharmaceutical composition suitable for treatment of haemophilia
10/31/2013WO2013159419A1 Use of seminal plasma
10/31/2013WO2013134269A3 Adhesive coacervates made of collagene - like proteins
10/31/2013WO2013115926A3 Aspartyl-trna synthetase-fc conjugates
10/31/2013WO2013111110A3 Synthetic apelin mimetics for the treatment of heart failure
10/31/2013WO2013090931A3 Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases
10/31/2013WO2013030673A3 Amphiphilic peptides for thoracic air leakage occlusion
10/31/2013WO2012130999A9 Peptides isolated and purified from fruit bat testicles
10/31/2013WO2004061073A9 Novel human proteins, polynucleotides encoding them and methods of using the same
10/31/2013WO2003023014A9 Human ion channels
10/31/2013WO2003020910A9 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL BETA-SUBUNIT, K+betaM8
10/31/2013WO2002101078A9 Cellulases, nucleic acids encoding them and methods for making and using them
10/31/2013WO2002098346A3 Method and pharmaceutical composition for the treatment of multiple sclerosis
10/31/2013WO2002087500A3 Viral enzyme activated prototoxophores and use of same to treat viral infections
10/31/2013WO2002078598A3 Peptides and antibodies to muc 1 proteins
10/31/2013WO2002077260A9 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/31/2013WO2002077001A9 Novel receptors
10/31/2013WO2002074973A9 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/31/2013WO2002069885A9 Anti-invasive and anti-angiogenic compositions and methods for treating brain tumors and other diseases
10/31/2013WO2002064559A3 Thrombin inhibitors
10/31/2013US20130288987 Melanocortin Receptor-Specific Peptides for Treatment of Female Sexual Dysfunction
10/31/2013US20130288984 Combination
10/31/2013US20130288983 Variant activin receptor polypeptides and uses thereof
10/31/2013US20130288982 Therapeutic agent for pulmonary small cell carcinoma
10/31/2013US20130288981 Targeting senescent cells and cancer cells by interference with jnk and/or foxo4
10/31/2013US20130288979 Inhibitors of Apoptosis and Uses Thereof
10/31/2013US20130288977 Method of regulating neuronal axon elongation
10/31/2013US20130288975 Methods of Treating Depression and Other Related Diseases
10/31/2013US20130288974 Method for ameliorating pain by modification of nmda receptors through inhibition of src
10/31/2013US20130288972 Compositions and Methods For The Treatment of Orthopedic Disease or Injury
10/31/2013US20130288969 Parathyroid hormone receptor activation and stem and progenitor cell expansion
10/31/2013US20130288968 Leuprolide injection
10/31/2013US20130288966 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
10/31/2013US20130288965 Use of peptides for promoting wound healing
10/31/2013US20130288964 Use of peptides for promoting wound healing
10/31/2013US20130288962 Methods and compositions for the repair and/or regeneration of damaged myocardium
10/31/2013US20130288958 Novel Glucagon Analogues
10/31/2013US20130288957 Oral combination therapy for treating hcv infection in specific patient subgenotype populations
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 3163